Results 191 to 200 of about 71,992 (213)
Glioblastoma resistance to EGFR antibody-drug conjugate is driven by transcriptional reprogramming and TEK-induced EGFR suppression. [PDF]
Blomquist MR +20 more
europepmc +1 more source
Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors. [PDF]
Rohrberg KS +39 more
europepmc +1 more source
Alternative splicing generates HER2 isoform diversity underlying antibody-drug conjugate resistance in breast cancer. [PDF]
Guardia GDA +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Hodgkin lymphoma: A review and update on recent progress
Ca-A Cancer Journal for Clinicians, 2018Satish P Shanbhag, Richard F Ambinder
exaly
Conjugate Additions of Nitroalkanes to Electron-Poor Alkenes: Recent Results
Chemical Reviews, 2005Roberto Ballini +2 more
exaly
Polymer–drug conjugate therapeutics: advances, insights and prospects
Nature Reviews Drug Discovery, 2018Iriny Ekladious +2 more
exaly

